Day One Biopharmaceuticals I logo

Day One Biopharmaceuticals I Share Price (NASDAQ: DAWN)

$7.5

-0.09

(-1.19%)

Last updated on

Check the interactive Day One Biopharmaceuticals I Stock chart to analyse performance

Day One Biopharmaceuticals I stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$7.41
    Today's High:$7.61

    Day's Volatility :2.63%

  • 52 Weeks Low:$5.64
    52 Weeks High:$16.76

    52 Weeks Volatility :66.38%

Day One Biopharmaceuticals I Stock Returns

PeriodDay One Biopharmaceuticals ISector (Health Care)Index (Russel 2000)
3 Months
7.06%
3.6%
0.0%
6 Months
-9.03%
-7.7%
0.0%
1 Year
-44.41%
-12.6%
0.0%
3 Years
-68.41%
10.2%
-4.1%

Day One Biopharmaceuticals I Key Stats

Check Day One Biopharmaceuticals I key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$7.59
Open
$7.61
Today's High
$7.61
Today's Low
$7.41
Market Capitalization
$777.5M
Today's Volume
$893.9K
52 Week High
$16.76
52 Week Low
$5.635
Revenue TTM
$187.6M
EBITDA
$-108.8M
Earnings Per Share (EPS)
$-0.89
Profit Margin
-50.63%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-24.75%

Stock Returns calculator for Day One Biopharmaceuticals I Stock including INR - Dollar returns

The Day One Biopharmaceuticals I stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Day One Biopharmaceuticals I investment value today

Current value as on today

₹60,840

Returns

₹39,160

(-39.16%)

Returns from Day One Biopharmaceuticals I Stock

₹44,444 (-44.44%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Day One Biopharmaceuticals I Stock

350%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Day One Biopharmaceuticals I Stock from India on INDmoney has increased by 350% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Day One Biopharmaceuticals I

  • Name

    Holdings %

  • FMR Inc

    13.38%

  • BlackRock Inc

    6.60%

  • Vanguard Group Inc

    6.03%

  • Franklin Resources Inc

    4.00%

  • Deerfield Management Co

    3.63%

  • Pictet Asset Manangement SA

    3.63%

Analyst Recommendation on Day One Biopharmaceuticals I Stock

Rating
Trend

Buy

    82%Buy

    11%Hold

    5%Sell

Based on 17 Wall street analysts offering stock ratings for Day One Biopharmaceuticals I(by analysts ranked 0 to 5 stars)

Day One Biopharmaceuticals I Share Price Target

What analysts predicted

Upside of 223.33%

Target:

$24.25

Current:

$7.50

Day One Biopharmaceuticals I share price target is $24.25, a slight Upside of 223.33% compared to current price of $7.50 as per analysts' prediction.

Day One Biopharmaceuticals I Stock Insights

  • Price Movement

    In the last 7 days, DAWN stock has moved up by 4.2%
  • DAWN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 115.7%
  • DAWN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 184.1%
  • Price to Sales

    ForDAWN every $1 of sales, investors are willing to pay $4.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Day One Biopharmaceuticals I Technicals Summary

Sell

Neutral

Buy

Day One Biopharmaceuticals I is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Day One Biopharmaceuticals I Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Day One Biopharmaceuticals I logo
12.86%
-9.03%
-44.41%
-68.41%
-65.49%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Day One Biopharmaceuticals I

Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
Organization
Day One Biopharmaceuticals I
Employees
182
CEO
Dr. Jeremy Bender M.B.A., Ph.D.
Industry
Healthcare

Key Management of Day One Biopharmaceuticals I

NameTitle
Dr. Jeremy Bender M.B.A., Ph.D.
CEO, President & Director
Mr. Charles N. York II, M.B.A.
COO & CFO
Mr. Adam Dubow J.D.
General Counsel, Chief Compliance Officer & Secretary
Mr. John Stubenrauch Ph.D.
Chief Technology Officer
Mr. Joey Perrone
Senior Vice President of Finance & Investor Relations
Ms. Jaa Roberson
Chief People Officer
Dr. Davy Chiodin Ph.D., Pharm.D.
Chief Development Officer
Ms. Lauren Merendino M.B.A.
Chief Commercial Officer
Dr. Elly Barry M.D.
Chief Medical Officer
Dr. Michael J. Vasconcelles M.D., Ph.D.
Head of Research & Development

Important FAQs about investing in DAWN Stock from India :

What is Day One Biopharmaceuticals I share price today?

Day One Biopharmaceuticals I share price today is $7.50 as on at the close of the market. Day One Biopharmaceuticals I share today touched a day high of $7.61 and a low of $7.41.

What is the 52 week high and 52 week low for Day One Biopharmaceuticals I share?

Day One Biopharmaceuticals I share touched a 52 week high of $16.76 and a 52 week low of $5.64. Day One Biopharmaceuticals I stock price today i.e. is closed at $7.50, lower by 55.25% versus the 52 week high.

How to invest in Day One Biopharmaceuticals I Stock (DAWN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Day One Biopharmaceuticals I on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Day One Biopharmaceuticals I Shares that will get you 0.2000 shares as per Day One Biopharmaceuticals I share price of $7.50 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Day One Biopharmaceuticals I Stock (DAWN) from India?

Indian investors can start investing in Day One Biopharmaceuticals I (DAWN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Day One Biopharmaceuticals I stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Day One Biopharmaceuticals I share’s latest price of $7.50 as on August 30, 2025 at 1:29 am IST, you will get 1.3333 shares of Day One Biopharmaceuticals I. Learn more about fractional shares .

What are the returns that Day One Biopharmaceuticals I has given to Indian investors in the last 5 years?

Day One Biopharmaceuticals I stock has given -65.49% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?